EUGIA-METHOTREXATE DIN 02546515
Status: Approved
Holder: EUGIA PHARMA INC.
Health Canada record
| Active ingredient(s) | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01BA01 METHOTREXATE |
|---|
| Original market date | |
|---|
| Current status date | 19-Mar-2024 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Eugia Pharma Inc. — licence 3-002768, currently licensed, last inspection rating C (2026-02-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHOTREXATE (METHOTREXATE DISODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02509067 | ACH-METHOTREXATE | ACCORD HEALTHCARE INC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Marketed |
| 02182963 | APO-METHOTREXATE | APOTEX INC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Marketed |
| 02524023 | AURO-METHOTREXATE | AURO PHARMA INC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Marketed |
| 02562979 | JAMP METHOTREXATE | JAMP PHARMA CORPORATION | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Approved |
| 02534916 | M-METHOTREXATE | MANTRA PHARMA INC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Marketed |
| 02562839 | METHOTREXATE TABLETS, USP | PFIZER CANADA ULC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 10 MG | Approved |
| 02170698 | PMS-METHOTREXATE | PHARMASCIENCE INC | Tablet | METHOTREXATE (METHOTREXATE DISODIUM) 2.5 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 32918 | 2024-03-19 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement Between Two
Manufacturers |
Request a quote for EUGIA-METHOTREXATE
How to read a Canadian DIN record